Revelation Biosciences
REVB
13 hedge funds and large institutions have $984K invested in Revelation Biosciences in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
82% more capital invested
Capital invested by funds: $540K → $984K (+$445K)
63% more funds holding
Funds holding: 8 → 13 (+5)
1.13% more ownership
Funds ownership: 4.06% → 5.2% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$436K |
| 2 |
AC
Armistice Capital
New York
|
+$388K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$59.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$110K |
| 2 |
Jane Street
New York
|
-$21K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$758 |
| 4 |
Citigroup
New York
|
-$1 |
REVB Hedge Fund Activity: Q4 2025 in Review
13 institutional investors reported a position in Revelation Biosciences (REVB) for Q4 2025, worth a combined $984K — up 82% from $540K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new REVB positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $436K. The largest seller was DRW Securities, exiting entirely with an estimated $110K sold.
- 13 institutional investors held Revelation Biosciences (REVB) as of Q4 2025, up from 8 in Q3 2025.
- Funds reported $984K of Revelation Biosciences stock for Q4 2025, up 82% quarter-over-quarter.
- 8 funds opened new Revelation Biosciences positions in Q4 2025 and 3 closed out, a net change of +5 holders.
- The largest Revelation Biosciences buyer in Q4 2025 was Sabby Management, an estimated $436K added.
- The largest Revelation Biosciences seller in Q4 2025 was DRW Securities, an estimated $110K sold.
Based on aggregated 13F filings for Q4 2025.